Glycoursodeoxycholic Acid: A Key Ingredient for Pharmaceutical Development
The pharmaceutical industry continuously seeks advanced chemical compounds to drive innovation in drug discovery and development. Glycoursodeoxycholic Acid (GUDCA), with its CAS number 64480-66-6, represents a class of bile acids that hold significant promise for various therapeutic applications. As a trusted manufacturer and supplier, we provide the high-purity GUDCA essential for rigorous pharmaceutical research and development processes.
GUDCA, a conjugate of glycine and ursodeoxycholic acid, is recognized for its diverse biological activities, including antioxidant, anti-inflammatory, and cytoprotective effects. These properties make it a compound of interest for developing treatments for a range of conditions, from metabolic syndromes to gastrointestinal disorders and potentially neurodegenerative diseases. Pharmaceutical scientists looking to purchase Glycoursodeoxycholic acid for formulation studies or preclinical trials require a supplier that guarantees consistent quality and bulk availability.
Our company, as a manufacturer based in China, offers Glycoursodeoxycholic acid with exceptional purity, typically exceeding 98%. We understand the critical need for reliable chemical intermediates in pharmaceutical development. By ensuring a stable supply chain and offering competitive pricing, we empower our clients to procure the necessary quantities of GUDCA without compromising on quality or budget. We aim to be your preferred supplier for this important biochemical.
When considering Glycoursodeoxycholic acid for your next pharmaceutical project, choosing a reputable manufacturer is paramount. We provide comprehensive technical documentation and support to facilitate your integration of GUDCA into your research or manufacturing pipeline. If you are interested in sourcing Glycoursodeoxycholic acid, please contact us to discuss your specific requirements, obtain pricing information, and learn more about our capabilities as a leading supplier in the chemical industry.
Perspectives & Insights
Data Seeker X
“GUDCA, a conjugate of glycine and ursodeoxycholic acid, is recognized for its diverse biological activities, including antioxidant, anti-inflammatory, and cytoprotective effects.”
Chem Reader AI
“These properties make it a compound of interest for developing treatments for a range of conditions, from metabolic syndromes to gastrointestinal disorders and potentially neurodegenerative diseases.”
Agile Vision 2025
“Pharmaceutical scientists looking to purchase Glycoursodeoxycholic acid for formulation studies or preclinical trials require a supplier that guarantees consistent quality and bulk availability.”